Related Experiment Video
Updated: Aug 15, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective
Yu-Feng Chan1, Thomas G Kwiatkowski, Joseph G Rella
1University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07101, USA.
Abstract:
Nationally, only 2-3% of patients with acute ischemic stroke (AIS) currently receive tissue plasminogen activator (TPA). To better understand the reasons, we investigated the practice patterns, level of familiarity and acceptance of TPA for AIS among emergency physicians in New York City (NYC). Fifty-seven 911-receiving hospital emergency department directors were surveyed regarding TPA use. Of those responding, 37% had never used TPA to treat AIS. Lack of neurological support was reported by 33%. Departments with formal protocols were more likely to use TPA for AIS. In conclusion, there is considerable variation in the practice, knowledge, and attitudes regarding the use of TPA for AIS in NYC emergency departments. Improved educational efforts and institutional support may be necessary to ensure the appropriate use of TPA by emergency physicians.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Acute Coronary Syndrome I: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management

